• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

OptiCept Technologies

2.90 SEK

+5.45 %

Less than 1K followers

OPTI

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+5.45 %
+60.40 %
+42.16 %
+13.28 %
+10.69 %
-34.61 %
-69.27 %
-93.20 %
-42.49 %

OptiCept Technologies provides the food and plant industry with technological solutions that are used to increase the sustainability of various raw materials. The company works with biological processes that provide increased extraction from the raw material, reduced waste and maintained taste, aroma, color, nutritional content. The company has a patented technology within PEF (pulsed electric field) and VI (Vacuum Infusion). The company sells its products on a global level. The headquarters are located in Lund.

Read more
Market cap
248.82M SEK
Turnover
498.34K SEK
Revenue
27.24M
EBIT %
-309.63 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Press releases
3rd party
ShowingAll content types

Forum discussions
OptiCept Technologies develops and provides technological solutions specifically designed for the needs of the food and plant industries. The company’s technologies focus on improving the sustainability and utilization of raw materials, enabling more efficient production while reducing...
8/31/2024, 12:07 PM
by Sijoittaja-alokas
3
@lucas.mattsson on tehnyt uuden analyysin OptiCeptistä. The capital raise announced on Friday reduces the financing risks and secures the company’s financing until the end of 2025. Due to the overall structure of the raise, we expect it to succeed. With short-term financing in check...
10/21/2024, 4:24 PM
by Sijoittaja-alokas
1
Here are @lucas.mattsson’s comments on OptiCept’s capital raise preliminarily reaching 70 percent of their subscription target, which maintains the company’s cash flow at nearly the expected level. Inderes OptiCept’s capital raise preliminary outcome at 70% of maximum gross proceeds...
11/27/2024, 11:36 AM
by Sijoittaja-alokas
0
OptiCept has signed a rental agreement with the Central American company Mexifrutas for the rental of an OptiCept PEF system to enhance pineapple juice extraction. A successful evaluation period could lead to long-term cooperation and help expand OptiCept’s commercial operations ...
10/16/2024, 6:45 PM
by Sijoittaja-alokas
0
OptiCept on ilmoittanut, että sen asiakas La Salud on saanut taloudellista tukea EU:lta, mikä oli tärkeä edellytys aiemmin tiedotetun kahden OliveCept-järjestelmän tilauksen etenemiselle. Tässä olisi Lucaksen kommentit asiaan liittyen. OptiCept has announced that its customer, La...
9/18/2024, 1:54 PM
by Sijoittaja-alokas
0
Here are Lucas’s comments regarding the options. OptiCept has reached an agreement to bring forward the exercise period for all outstanding warrants, resulting in the subscription of 4,350,000 shares worth around 13 MSEK. We had previously flagged that this was a possibility, so ...
9/12/2024, 7:50 AM
by Sijoittaja-alokas
0
Here are Lucas Mattsson’s comments on OptiCept signing a letter of intent (LOI) with Saab to explore a long-term partnership in Thailand aimed at improving productivity in the food and forestry industries. The cooperation could lead to new orders and a wider commercial scale in the...
9/9/2024, 10:19 PM
by Sijoittaja-alokas
0
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28/8
2026

Interim report Q2'26

28/11
2026

Interim report Q3'26

5/3
2027

Annual report '26

Press release6/3/2026, 6:45 AM

OptiCept – Ytterligare en order för FPS i Nederländerna

OptiCept Technologies
Press release6/3/2026, 6:45 AM

OptiCept - New order for FPS in the Netherlands

OptiCept Technologies
Press release6/2/2026, 6:55 AM

DNB Carnegie Access: OptiCept Technologies: The path to positive EBITDA is paved – Q1 review

OptiCept Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release6/1/2026, 12:00 PM

Intervju med FPS

OptiCept Technologies
Press release6/1/2026, 12:00 PM

Interview with FPS

OptiCept Technologies
Press release5/29/2026, 6:30 AM

OptiCept - Ny order för FPS USA

OptiCept Technologies
Press release5/29/2026, 6:30 AM

OptiCept - New order for FPS USA

OptiCept Technologies
Regulatory press release5/29/2026, 6:00 AM

Opticept Technologies AB (Publ) Delårsrapport för kvartal 1 2026

OptiCept Technologies
Regulatory press release5/29/2026, 6:00 AM

OptiCept Technologies AB (Publ) Interim Report for the first quarter 2026

OptiCept Technologies
Press release5/25/2026, 6:00 AM

OptiCept inkluderat i ny stororder för FPS

OptiCept Technologies
Press release5/25/2026, 6:00 AM

OptiCept part of new major order for FPS

OptiCept Technologies
Regulatory press release5/21/2026, 9:30 AM

Kommuniké från årsstämma i OptiCept Technologies AB (publ) den 21 maj 2026

OptiCept Technologies
Regulatory press release5/21/2026, 9:30 AM

Bulletin from annual general meeting of OptiCept Technologies AB (publ) on 21 May 2026

OptiCept Technologies
Press release5/13/2026, 12:30 PM

PM: Förändring styrelseordförande – OptiCept Technologies AB

OptiCept Technologies
Press release5/13/2026, 12:30 PM

PM: Change of Chairman of the Board – OptiCept Technologies AB

OptiCept Technologies
Press release5/6/2026, 7:15 AM

OptiCept Technologies AB (publ) - Första licensavgiften från FPS och lageravyttringen är betald. Intäkten uppgår till 21 Mkr.

OptiCept Technologies
Press release5/6/2026, 7:15 AM

OptiCept Technologies AB (publ) - The first license fee from FPS and the stock sale has been paid. Revenue amounts to SEK 21 million.

OptiCept Technologies
Regulatory press release4/21/2026, 7:30 PM

OptiCept Technologies AB publicerar årsredovisning för 2025

OptiCept Technologies
Regulatory press release4/20/2026, 2:30 PM

Kallelse till årsstämma i OptiCept Technologies AB (publ)

OptiCept Technologies
Press release3/31/2026, 4:29 AM

DNB Carnegie Access: OptiCept Technologies: Stage set for transformational 2026 – Q4 review

OptiCept Technologies